Suivre
Gareth Veal
Gareth Veal
Professor of Cancer Pharmacology, Newcastle University
Adresse e-mail validée de ncl.ac.uk - Page d'accueil
Titre
Citée par
Citée par
Année
Human renal function maturation: a quantitative description using weight and postmenstrual age
MM Rhodin, BJ Anderson, AM Peters, MG Coulthard, B Wilkins, M Cole, ...
Pediatric nephrology 24 (1), 67-76, 2009
4432009
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised …
B Seddon, SJ Strauss, J Whelan, M Leahy, PJ Woll, F Cowie, ...
The lancet oncology 18 (10), 1397-1410, 2017
3102017
Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapies
N Widmer, C Bardin, E Chatelut, A Paci, J Beijnen, D Levêque, G Veal, ...
European journal of cancer 50 (12), 2020-2036, 2014
3002014
Review of therapeutic drug monitoring of anticancer drugs part 1–cytotoxics
A Paci, G Veal, C Bardin, D Levêque, N Widmer, J Beijnen, A Astier, ...
European journal of cancer 50 (12), 2010-2019, 2014
2352014
Sodium thiosulfate for protection from cisplatin-induced hearing loss
PR Brock, R Maibach, M Childs, K Rajput, D Roebuck, MJ Sullivan, ...
New England Journal of Medicine 378 (25), 2376-2385, 2018
1842018
Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells
JL Armstrong, R Flockhart, GJ Veal, PE Lovat, CPF Redfern
Journal of Biological Chemistry 285 (9), 6091-6100, 2010
1692010
Metabolism of zidovudine
GJ Veal, DJ Back
General pharmacology: The vascular system 26 (7), 1469-1475, 1995
1291995
Therapeutic drug monitoring in cancer–are we missing a trick?
C Bardin, G Veal, A Paci, E Chatelut, A Astier, D Levêque, N Widmer, ...
European journal of cancer 50 (12), 2005-2009, 2014
1162014
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
MG Barry, SH Khoo, GJ Veal, PG Hoggard, SE Gibbons, EG Wilkins, ...
AIDS (London, England) 10 (12), 1361-1367, 1996
1161996
Clinical pharmacology in the adolescent oncology patient
GJ Veal, CM Hartford, CF Stewart
Journal of clinical oncology 28 (32), 4790, 2010
1072010
Lamivudine (3TC) phosphorylation and drug interactions in vitro
S Kewn, GJ Veal, PG Hoggard, MG Barry, DJ Back
Biochemical pharmacology 54 (5), 589-595, 1997
1011997
Oxazaphosphorines: new therapeutic strategies for an old class of drugs
B Giraud, G Hebert, A Deroussent, GJ Veal, G Vassal, A Paci
Expert opinion on drug metabolism & toxicology 6 (8), 919-938, 2010
922010
A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin
GJ Veal, MJ Griffin, E Price, A Parry, GS Dick, MA Little, SM Yule, ...
British journal of cancer 84 (8), 1029-1035, 2001
892001
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
M Barry, M Wild, G Veal, D Back, A Breckenridge, R Fox, N Beeching, ...
AIDS (London, England) 8 (8), F1-5, 1994
781994
The oncogenic transcription factor RUNX1/ETO corrupts cell cycle regulation to drive leukemic transformation
N Martinez-Soria, L McKenzie, J Draper, A Ptasinska, H Issa, S Potluri, ...
Cancer Cell 34 (4), 626-642. e8, 2018
762018
13-cis retinoic acid and isomerisation in paediatric oncology—is changing shape the key to success?
JL Armstrong, CPF Redfern, GJ Veal
Biochemical pharmacology 69 (9), 1299-1306, 2005
722005
Clinical and cellular pharmacology in relation to solid tumours of childhood
EJ Estlin, GJ Veal
Cancer treatment reviews 29 (4), 253-273, 2003
692003
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
GJ Veal, M Cole, J Errington, A Parry, J Hale, ADJ Pearson, K Howe, ...
Clinical cancer research 11 (16), 5893-5899, 2005
662005
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy
GJ Veal, C Dias, L Price, A Parry, J Errington, J Hale, ADJ Pearson, ...
Clinical cancer research 7 (8), 2205-2212, 2001
612001
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the …
GJ Veal, L Nguyen, A Paci, M Riggi, M Amiel, D Valteau-Couanet, P Brock, ...
European Journal of Cancer 48 (16), 3063-3072, 2012
592012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20